» Articles » PMID: 33761957

Regulation of Autophagy by MicroRNAs in Human Breast Cancer

Overview
Journal J Biomed Sci
Publisher Biomed Central
Specialty Biology
Date 2021 Mar 25
PMID 33761957
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

Breast cancer is the most common solid cancer that affects female population globally. MicroRNAs (miRNAs) are short non-coding RNAs that can regulate post-transcriptional modification of multiple downstream genes. Autophagy is a conserved cellular catabolic activity that aims to provide nutrients and degrade un-usable macromolecules in mammalian cells. A number of in vitro, in vivo and clinical studies have reported that some miRNAs could modulate autophagy activity in human breast cancer cells, and these would influence human breast cancer progression and treatment response. Therefore, this review was aimed to discuss the roles of autophagy-regulating miRNAs in influencing breast cancer development and treatment response. The review would first introduce autophagy types and process, followed by the discussion of the roles of different miRNAs in modulating autophagy in human breast cancer, and to explore how would this miRNA-autophagy regulatory process affect the disease progression or treatment response. Lastly, the potential applications and challenges of utilizing autophagy-regulating miRNAs as breast cancer biomarkers and novel therapeutic agents would be discussed.

Citing Articles

MicroRNA-mediated autophagy and drug resistance in cancer: mechanisms and therapeutic strategies.

Wei J, Wang X, Yu D, Tu Y, Yu Y Discov Oncol. 2024; 15(1):662.

PMID: 39549162 PMC: 11569378. DOI: 10.1007/s12672-024-01525-9.


Role of Non-coding RNAs on the Radiotherapy Sensitivity and Resistance in Cancer Cells.

Jalali-Zefrei F, Mousavi S, Delpasand K, Shourmij M, Farzipour S Curr Gene Ther. 2024; 25(2):113-135.

PMID: 38676526 DOI: 10.2174/0115665232301727240422092311.


MicroRNA-183 cluster: a promising biomarker and therapeutic target in gastrointestinal malignancies.

Zheng Y, Sukocheva O, Tse E, Neganova M, Aleksandrova Y, Zhao R Am J Cancer Res. 2024; 13(12):6147-6175.

PMID: 38187051 PMC: 10767355.


miRNA Expression Profiling in Human Breast Cancer Diagnostics and Therapy.

Dziechciowska I, Dabrowska M, Mizielska A, Pyra N, Lisiak N, Kopczynski P Curr Issues Mol Biol. 2023; 45(12):9500-9525.

PMID: 38132441 PMC: 10742292. DOI: 10.3390/cimb45120595.


Electroacupuncture ameliorates AOM/DSS-induced mice colorectal cancer by inhibiting inflammation and promoting autophagy via the SIRT1/miR-215/Atg14 axis.

Li J, Han Y, Zhou M, Liu N, Li H, Huang G Aging (Albany NY). 2023; 15(22):13194-13212.

PMID: 38006398 PMC: 10713401. DOI: 10.18632/aging.205236.


References
1.
Soni M, Patel Y, Markoutsa E, Jie C, Liu S, Xu P . Autophagy, Cell Viability, and Chemoresistance Are Regulated By miR-489 in Breast Cancer. Mol Cancer Res. 2018; 16(9):1348-1360. PMC: 6843115. DOI: 10.1158/1541-7786.MCR-17-0634. View

2.
Ji X, Lu Y, Tian H, Meng X, Wei M, Cho W . Chemoresistance mechanisms of breast cancer and their countermeasures. Biomed Pharmacother. 2019; 114:108800. DOI: 10.1016/j.biopha.2019.108800. View

3.
Meijer A, Lorin S, Blommaart E, Codogno P . Regulation of autophagy by amino acids and MTOR-dependent signal transduction. Amino Acids. 2014; 47(10):2037-63. PMC: 4580722. DOI: 10.1007/s00726-014-1765-4. View

4.
Mayya V, Duchaine T . Ciphers and Executioners: How 3'-Untranslated Regions Determine the Fate of Messenger RNAs. Front Genet. 2019; 10:6. PMC: 6357968. DOI: 10.3389/fgene.2019.00006. View

5.
Sun Q, Liu T, Yuan Y, Guo Z, Xie G, Du S . MiR-200c inhibits autophagy and enhances radiosensitivity in breast cancer cells by targeting UBQLN1. Int J Cancer. 2014; 136(5):1003-12. DOI: 10.1002/ijc.29065. View